Voice Quality Analysis of Patients With Laryngotracheal Stenosis

Recruiting in Palo Alto (17 mi)

Overseen by Alexander Hillel, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Johns Hopkins University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) have highlighted the use of artificial intelligence to identify acoustic biomarkers of disease. Therefore, the investigators hypothesize that progression of LTS scar can be quantified using acoustic measurements and machine learning. The goal of this clinical trial is to remotely monitor patient voice quality in an effort to determine if regularly performed voice recordings can be used as a diagnostic tool in order to predict the need for dilation procedures. The investigators feel that successful use of remote voice recording technology with algorithmic analysis will improve patient quality of life.

Eligibility Criteria

Inclusion Criteria

You need to understand the information about the study and give permission by signing a form.

You need to have records showing when you were diagnosed with laryngotracheal stenosis and details about any previous treatments or surgeries.

You currently have a diagnosis of a narrowed airway in your throat.

Participant Groups

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Johns Hopkins Outpatient Center Baltimore, MD

Who Is Running the Clinical Trial?

Johns Hopkins University Lead Sponsor

References